2.Progress on molecular biology of delta6-fatty acid desaturases.
Qi ZHANG ; Ming-Chun LI ; Hong-Yan SUN ; Ying SUN ; Hai-Ting MA ; Lai-Jun XING
Chinese Journal of Biotechnology 2004;20(3):319-324
Polyunsaturated fatty acids (PUFAs) including gamma-linolenic acid are valuable products because of their involvement in several aspects of human health care. GLA has been claimed to play a crucial role in development and prevention of some skin diseases, diabetes, reproductive disorder and others. At present, market demand for most gamma-linolenic acid is growing continually and current sources are inadequate for satisfying this demand due to the significant problems of low productivity, complex and expensive downstream process and unstable quality. Therefore, seeking for alternative sources are demanding. delta6-fatty acid desaturase is the rate-limiting enzyme for the biosynthesis of PUFAs, which catalyses the conversion of linoleic acid and alpha-linolenic acid to gamma-linolenic acid and stearidonic acid respectively. Unfortunately, the structure information on membrane desaturases is scarce because of the technical limitations in obtaining quantities of purified protein and the intrinsic difficulties in obtaining crystals from membrane proteins. With the isolation of the genes coding for delta6-fatty acid desaturase from various organisms, its characteristics will be elucidated gradually. Here we concisely reviewed the recent progress on studies of molecular biology including the cloning of delta6-fatty acid desaturase gene, structure and function, phylogeny and prospects of gene engineering application.
Cloning, Molecular
;
Fatty Acid Desaturases
;
genetics
;
metabolism
;
Fatty Acids, Unsaturated
;
biosynthesis
;
Genetic Engineering
;
methods
;
Phylogeny
;
gamma-Linolenic Acid
;
biosynthesis
3.Effects of Gamma-Linolenic Acid for the Treatment of Acne Vulgaris Treated with Isotretinoin.
Myeong Gil JEONG ; Jeong Eun KIM ; Ji Young AHN ; Joo Yeon KO ; Mi Youn PARK ; Young Suck RO
Korean Journal of Dermatology 2013;51(11):863-870
BACKGROUND: Oral isotretinoin is an effective treatment modality for acne, but this agent may cause dryness of the skin and mucous membrane. Gamma-linolenic acid (GLA) has been known to improve skin moisture and reduce transepidermal water loss (TEWL). It is also known to have anti-inflammatory effects and to inhibit 5-alpha reductase. OBJECTIVE: This study was performed to evaluate the clinical efficacy of GLA in the prevention of xerosis and improvement of acne lesions after concomitant administration of isotretinoin. METHODS: In this prospective study, 102 Korean acne patients were enrolled and randomized to receive isotretinoin either with or without GLA for 12 weeks. Comparing evaluations included skin hydration, TEWL, visual analogue scale (VAS) score for dryness of the lips and skin, number of acne lesions such as comedos, papules, and pustules, Korean acne grading system (KAGS) grade, and patient satisfaction regarding treatment. RESULTS: The decrease of skin hydration and increase of the TEWL of the lips and cheek were less definite in the experimental group than those of the control group. VAS score for dryness of the lips and skin was significantly lower in the experimental group compared with the control group. The number of acne lesions decreased in both groups; only the numbers of papules were different between the two groups. The decrease of the KAGS grade was more definite in the experimental group than that in the control group. CONCLUSION: This study suggests that GLA could be used effectively for the improvement of acne lesions as well as for the prevention of xerosis.
Acne Vulgaris*
;
Cheek
;
gamma-Linolenic Acid*
;
Humans
;
Isotretinoin*
;
Lip
;
Mucous Membrane
;
Oxidoreductases
;
Patient Satisfaction
;
Prospective Studies
;
Skin
4.Dose-Dependent Effects of Evening Primrose Oil in Children and Adolescents with Atopic Dermatitis.
Bo Young CHUNG ; Jin Hye KIM ; Soo Ick CHO ; In Su AHN ; Hye One KIM ; Chun Wook PARK ; Cheol Heon LEE
Annals of Dermatology 2013;25(3):285-291
BACKGROUND: Previous clinical trials with evening primrose oil in atopic dermatitis (AD) treatment have shown different results. In addition, the optimal dose and duration of treatment with evening primrose oil have not yet been determined. OBJECTIVE: The aim of this study is to investigate the dose-response treatment effects of evening primrose oil on clinical symptoms of AD and serum concentrations of polyunsaturated fatty acids. METHODS: Forty AD patients were enrolled for the study and randomly divided into 2 groups: those who received evening primrose oil 160 mg daily for 8 weeks and those who received 320 mg of evening primrose oil twice daily for 8 weeks. We evaluated the Eczema Area Severity Index (EASI) scores of all AD patients at weeks 0, 2, 4 and 8. In addition, we measured the levels of serum fatty acids, including C16 : 0 (palmitic), C18 : 2n (linoleic), C18 : 3n (linolenic) and C20 : 4 (arachidonic acid) using gas chromatography. RESULTS: The serum fatty acid levels C18 : 3n and C20 : 4 were higher in the 320 mg group than in the 160 mg group, with statistical significance. After evening primrose oil treatment, EASI scores were reduced in the 2 groups. The improvement in EASI scores was greater in the 320 mg group than in the 160 mg group. There were no side effects seen in either group during the study in the 2 groups. CONCLUSION: The results of this study suggest that the 320 mg and 160 mg groups may be equally effective in treating AD patients and show dose-dependent effects on serum fatty acid levels and EASI scores.
Adolescent
;
Child
;
Dermatitis, Atopic
;
Eczema
;
Fatty Acids
;
gamma-Linolenic Acid
;
Humans
;
Linoleic Acids
;
Oenothera biennis
;
Plant Oils
5.Dose-Dependent Effects of Evening Primrose Oil in Children and Adolescents with Atopic Dermatitis.
Bo Young CHUNG ; Jin Hye KIM ; Soo Ick CHO ; In Su AHN ; Hye One KIM ; Chun Wook PARK ; Cheol Heon LEE
Annals of Dermatology 2013;25(3):285-291
BACKGROUND: Previous clinical trials with evening primrose oil in atopic dermatitis (AD) treatment have shown different results. In addition, the optimal dose and duration of treatment with evening primrose oil have not yet been determined. OBJECTIVE: The aim of this study is to investigate the dose-response treatment effects of evening primrose oil on clinical symptoms of AD and serum concentrations of polyunsaturated fatty acids. METHODS: Forty AD patients were enrolled for the study and randomly divided into 2 groups: those who received evening primrose oil 160 mg daily for 8 weeks and those who received 320 mg of evening primrose oil twice daily for 8 weeks. We evaluated the Eczema Area Severity Index (EASI) scores of all AD patients at weeks 0, 2, 4 and 8. In addition, we measured the levels of serum fatty acids, including C16 : 0 (palmitic), C18 : 2n (linoleic), C18 : 3n (linolenic) and C20 : 4 (arachidonic acid) using gas chromatography. RESULTS: The serum fatty acid levels C18 : 3n and C20 : 4 were higher in the 320 mg group than in the 160 mg group, with statistical significance. After evening primrose oil treatment, EASI scores were reduced in the 2 groups. The improvement in EASI scores was greater in the 320 mg group than in the 160 mg group. There were no side effects seen in either group during the study in the 2 groups. CONCLUSION: The results of this study suggest that the 320 mg and 160 mg groups may be equally effective in treating AD patients and show dose-dependent effects on serum fatty acid levels and EASI scores.
Adolescent
;
Child
;
Dermatitis, Atopic
;
Eczema
;
Fatty Acids
;
gamma-Linolenic Acid
;
Humans
;
Linoleic Acids
;
Oenothera biennis
;
Plant Oils
6.Separation of gamma linolenic acid from evening primrose oil with urea inclusion--orthogonal experiment of optimizing technological parameters and observation of urea inclusion compound I.
Hua WANG ; Man LING ; Gang XUE ; Fengxia LIU ; Shuxian GUO
China Journal of Chinese Materia Medica 2010;35(10):1251-1255
OBJECTIVEThe influence on the urea inclusion compound under different conditions (allocated proportion, time of inclusion, temperature of inclusion) were studied through the orthogonal test, and theoretical reference of urea inclusion process for further optimization wound be offered.
METHODThe orthogonal experiment was adopted, and microscope was used to observe the shape, aperture size of the urea inclusion compound under different technological parameters, the GC was employed to inspect the purity of GLA.
RESULTThe results indicated that the ratio of fatty acids and urea, inclusion of temperature, time of inclusion had great effect on urea inclusion compound. The three factors and its interactions significantly affected the purity of GLA. The results also showed that the best process was that the ratio of fatty acids and urea was 1 : 3, temperature of inclusion was--15 degrees C, time of inclusion was 24 h.
CONCLUSIONUnder the best condition, the purity of GLA reach up to 95.575 9%; and it is feasible to observe the shape and the amount of the urea inclusion compound to reflect and guide the urea inclusion technology.
Oenothera biennis ; chemistry ; Plant Oils ; chemistry ; Technology, Pharmaceutical ; methods ; Temperature ; Urea ; chemistry ; gamma-Linolenic Acid ; analysis ; isolation & purification
7.The efficacy of evening primrose oil as a cervical ripening agent for gynecologic procedures: A single-blinded, randomized controlled trial.
Verano Rusienne Mae A. ; Veloso-Borromeo Mary Girlie
Philippine Journal of Obstetrics and Gynecology 2015;39(1):25-28
BACKGROUND: Evening Primrose Oil (EPO) is one of the most commonly prescribed cervical ripening agents. Cervical ripening is the softening, effacement, and dilation of the cervix that occur prior to active labor, and is an intervention that is used for certain indications, such as postdates pregnancy. There are gynecologic cases wherein the cervix is closed and dilatation has not occurred making the procedure difficult. In studies, EPO works by softening and ripening the cervix in the pregnant woman. More likely it has the same effects in a non-pregnant patient with regards to softening and dilating the cervix during gynecologic procedures.
METHODS: The study was conducted in a tertiary hospital. Patients scheduled for gynecologic procedures were randomly grouped under the control and study group. Both groups had an internal examination during admission. The study group, in addition, were given EPO 4 capsules intra-vaginally, 6 hours prior to the contemplated procedure. Cervical characteristics were assessed initially on admission and pre-proedure.
Consistency were assessed using the Consistency Index (CI) and graded as firm=1, medium=2 and soft=3. Dilatation were assessed using the Dilatation Index (DI) and graded as closed=1, admits tip =2 , >1cm= 3. Pre-procedure, cervical characteristics and the CDI of both groups were assessed. Hegars dilators were used to assess the degree of dilatation, noting the diameter of dilator that can be introduced freely, and to what diameter the cervix can be maximally dilated.
RESULTS: 80 patients were enrolled in the study; 39 patients were assigned in the control group and 38 patients were assigned in the study group (3 were excluded). In the study group, their DI improved by 36.2% (pre = 1.53+/-0.51 to post = 2.08+/-0.49) (p<0.001), CI increased by 115.9% (pre=1.16+/-0.37 to post = 2.50+/-0.65) (p<0.001), and their CDI changed by 70.6% (pre=2.68+/-0.74 to post = 4.58+/-0.95) (p<0.001). The changes of scores in all the cervical parameters in the study group were statistically significant.
CONCLUSION: EPO 4 capsules punctured and administered intra-vaginally 6 hours prior to contemplated gynecologic procedure can promote cervical ripening as exhibited by the improvement of the CDI from initial assessment to pre-procedure assessment.
Human ; Female ; Pregnancy ; Cervical Ripening ; Cervix Uteri ; Efamol ; Dilatation ; Capsules ; Gamma-linolenic Acid ; Linoleic Acids ; Plant Oils ; Administration, Intravaginal
8.The Effect of Isoflavone and Gamma-linolenic Acid Supplementation on Serum Lipids and Menopausal Symptoms in Postmenopausal Women.
Jung Hyun GWAK ; Ji Young KIM ; Hyae Jin KIM ; Dong Hyeok SHIN ; Jong Ho LEE
The Korean Journal of Nutrition 2010;43(2):123-131
This study was performed to examine the combined effects of gamma linolenic acid and isoflavone supplementation on menopausal symptoms and serum lipids in 73 postmenopausal women. A total subjects were randomly assigned to isoflavone (30 mg) + gamma-linolenic acid (110 mg) group or placebo group. We measured menopausal symptoms by modified Kupperman Index (KI) and oxidized LDL, lipid peroxides, blood components and anthropometric parameters before and after the 12 week intervention period. After the 12 weeks of supplementation, supplement group and placebo group showed a significant reduction of modified kupperman index (p < 0.001). Isoflavone (30 mg) + gamma-linolenic acid (110 mg) supplement group showed a significant reduction of oxidized LDL cholesterol concentration (p = 0.006) whereas placebo group did not show significant change. Isoflavone and gamma-linolenic acid consumption did not significantly affect plasma concentrations of total, LDL, HDL cholesterol, triglyceride, apo A1, B and blood components. The result of present study demonstrated the supplementation of 30 mg isoflavone and 110 mg gamma-linolenic acid per day for 12 weeks may protect LDL cholesterol from oxidative stress.
Apolipoprotein A-I
;
Cholesterol, HDL
;
Cholesterol, LDL
;
Female
;
gamma-Linolenic Acid
;
Humans
;
Lipid Peroxides
;
Lipoproteins, LDL
;
Oxidative Stress
;
Plasma
9.Nutritional supplements.
Journal of the Korean Medical Association 2012;55(9):889-897
A dietary supplement, also known as a food supplement or nutritional supplement, is a preparation intended to supplement the diet and provide nutrients, such as vitamins, minerals, fiber, fatty acids, or amino acids. A health functional food is a food where one or more new ingredients have been added to a food and the new product has an additional function. Physicians and patients need information on current evidence on the efficacy and safety of selected dietary supplements that are commonly used. The current evidence on the efficacy and safety of selected dietary supplements (beta-carotene, vitamin C, D, E, calcium, selenium, omega 3, ginseng, glucosamine, chlorella, saw palmetto, gingko, gamma linolenic acid, echinacea) for specific conditions is assessed by an evidence-based approach. With an increase in income and the aging of the population, spending on dietary supplements is steadily increasing, but concern about the safety and efficacy of dietary supplements may be relatively low. Recently, many domestic and international clinical trials on nutritional supplements have been performed. As a result, the evidence on the efficacy and safety of dietary supplements may be changed or recommendations may also be changed. Greater efforts should be made to acquire the latest knowledge about dietary supplements.
Aging
;
Amino Acids
;
Ascorbic Acid
;
Calcium
;
Chlorella
;
Diet
;
Dietary Supplements
;
Evidence-Based Medicine
;
Fatty Acids
;
Functional Food
;
gamma-Linolenic Acid
;
Ginkgo biloba
;
Glucosamine
;
Humans
;
Minerals
;
Panax
;
Selenium
;
Vitamins
10.Effect of Evening Primrose Oil on Korean Patients With Mild Atopic Dermatitis: A Randomized, Double-Blinded, Placebo-Controlled Clinical Study.
Bo Young CHUNG ; Sook Young PARK ; Min Je JUNG ; Hye One KIM ; Chun Wook PARK
Annals of Dermatology 2018;30(4):409-416
BACKGROUND: Atopic dermatitis (AD) is related to a deficiency of delta-6-desaturase, an enzyme responsible for converting linoleic acid to gamma-linolenic acid (GLA). Evening primrose oil (EPO) as a source of GLA has been of interest in the management of AD. OBJECTIVE: The aim of this randomized, double-blinded, placebo-controlled clinical study is to evaluate the efficacy and safety of EPO in Korean patients with AD. METHODS: Fifty mild AD patients with an Eczema Area Severity Index (EASI) score of 10 or less were enrolled and randomly divided into two groups. The first group received an oval unmarked capsule containing 450 mg of EPO (40 mg of GLA) per capsule, while placebo capsules identical in appearance and containing 450 mg of soybean oil were given to the other group. Treatment continued for a period of four months. EASI scores, transepidermal water loss (TEWL), and skin hydration were evaluated in all the AD patients at the baseline, and in months 1, 2, 3, and 4 of the study. RESULTS: At the end of month 4, the patients of the EPO group showed a significant improvement in the EASI score (p=0.040), whereas the patients of the placebo group did not. There was a significant difference in the EASI score between the EPO and placebo groups (p=0.010). Although not statistically significant, the TEWL and skin hydration also slightly improved in the EPO patients group. CONCLUSION: We suggest that EPO is a safe and effective medicine for Korean patients with mild AD.
Capsules
;
Clinical Study*
;
Dermatitis, Atopic*
;
Eczema
;
gamma-Linolenic Acid
;
Humans
;
Linoleic Acid
;
Linoleoyl-CoA Desaturase
;
Oenothera biennis*
;
Skin
;
Soybean Oil
;
Water